In 2022 the company made a revenue of $24.99 M an increase over the years 2021 revenue that were of $9.73 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | -100% |
2022 | $24.99 M | 156.83% |
2021 | $9.73 M | -45.65% |
2020 | $17.9 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | N/A | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | N/A | ๐บ๐ธ USA |
Merck MRK | $60.11 B | N/A | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | N/A | ๐ฎ๐ฑ Israel |
Hawkins HWKN | $0.92 B | N/A | ๐บ๐ธ USA |
Quaker Houghton KWR | $1.95 B | N/A | ๐บ๐ธ USA |